Cost-Effectiveness and Benefit-To-Harm Ratio of Risk-Stratified Screening for Breast Cancer
JAMA Oncology - United States
doi 10.1001/jamaoncol.2018.1901
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2018
Authors
Publisher
American Medical Association (AMA)